J1730 HCPCS Level II code: Injection, diazoxide, up to 300 mg
J1730 is the HCPCS code for “Injection, diazoxide, up to 300 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J1730Injection, diazoxide, up to 300 mg
Short description: Diazoxide injection
HCPCS · United States
Medicare details
The indicators CMS publishes with J1730 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 1982
Where J1730 sits
- 1J codesDrugs administered other than orally
- 2Active code J1730Injection, diazoxide, up to 300 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J1730 mean?
J1730 is the HCPCS code for “Injection, diazoxide, up to 300 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J1730?
CMS lists J1730’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J1730
All J codesJ1700Injection, hydrocortisone acetate, up to 25 mgJ1710Injection, hydrocortisone sodium phosphate, up to 50 mgJ1720Injection, hydrocortisone sodium succinate, up to 100 mgJ1725Injection, hydroxyprogesterone caproate, 1 mgJ1726Injection, hydroxyprogesterone caproate, (makena), 10 mgJ1729Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mgJ1736Injection, meloxicam (delova), 1 mgJ1737Injection, meloxicam (azurity), 1 mgJ1738Injection, meloxicam, 1 mgJ1740Injection, ibandronate sodium, 1 mgJ1741Injection, ibuprofen, 100 mgJ1742Injection, ibutilide fumarate, 1 mg